Central Drugs Laboratory (CDL) Kolkata
The Central Drugs Laboratory, Kolkata is the national statutory laboratory of the Government of India for quality control of Drug and Cosmetics and is established under the Indian Drug & Cosmetics Act, 1940. It is the oldest quality control laboratory of the Drug Control Authorities in India. It functions under the administrative control of the Director-General of Health Services in the Ministry of Health and Family Welfare.
The functions of the Laboratory include:
I. Statutory Functions:
(a) Analytical quality control of majority of the imported Drug available in Indian market.
(b) Analytical quality control of drug and cosmetics manufactured within the country on behalf of the Central and State Drug Controller Administrations.
(c) Acting as an Appellate authority in matters of disputes relating to quality of Drug.
II. Other Funtions:
(a) Collection, storage and distribution of International Standard International Reference Preparations of Drug and Pharmaceutical Substances.
(b) Preparation of National Reference Standards and maintenance of such Standards. Maintenance of microbial cultures useful in drug analysis Distribution of Standards and cultures to State Quality Control Laboratories and drug manufacturing establishments.
(c) Training of Drug Analysts deputed by State Drug Control Laboratories and other Institutions.
(d) Training of World Health Organisation Fellows from abroad on modern methods of Drug Analysis.
(e) To advise the Central Drug Control Administration in respect of quality and toxicity of drug awaiting licence.
(f) To work out analytical specifications for preparation of Monographs for the Indian Pharmacopoeia and the Homoeopathic Pharmacopoeia of India.
(g) To undertake analytical research on standardisation and methodology of Drug and cosmetics.
(h) Analysis of Cosmetics received as survey samples from Central Drug Standard Control Organisation.
(i) Quick analysis of life saving Drug on an All-India basis received under National Survey of Quality of Essential Drug Programme from Zonal Offices of Central Drug Standard Control Organisation.
In addition to the above functions the Central Drug Laboratory also actively collaborates with the World Health Organisation in the preparation of International Standards and Specifications for International Pharmacopoeia. It also undertakes collaborative study on behalf of the Indian Pharmacopoeia Committee. The senior Officers of the Laboratory have been appointed as Government Analysts on behalf of most of the States of the Union for analysis of drug samples.
The Director of CDL is Dr.P.K.Guha, Director, Central Drugs Laboratory, 3, Kyd Street, Kolkata – 700 016. Phone : 033 -22299541, Gram : BIOSTANLAB. Fax: 033-22299380.
Central Drugs Testing laboratory(CDTL) Mumbai
Accredited By: NABL (ISO/IEC-17025:2005 in Chemical and Biological Testing)
Certified for: IMS (ISO-9001:2008, ISO-14001:2004, OHSAS-18001:2007
The CDTL, Mumbai is one of the National Statutory Laboratories of the Government of India, functioning under administrative control of the Drug Controller General (India), Central Drugs Standard Control Organization (CDSCO), Directorate General of Health Services, Ministry of Health and Family Welfare, New Delhi. Dr. Raman Mohan Singh is the Director of the Laboratory from 7th May 2015. Contact Detials:
Address: Zonal FDA Bhawan, Bellasis Road, Governement Medical Stores Depot (GMSD) Compound, Mumbai Central, Mumbai-400 008. Phone Numbers: Office: 022-2300 2309, 2300 2138. Telefax: 022-23099240.
E-mail: firstname.lastname@example.org, email@example.com
The statutory and other major functions of the laboratory include:
Analysis of Drugs and Pharmaceuticals, Cosmeitcs and Medical Devices manufactured in the country.
The Director, CDTL mumbai Acts as “Appellate Authority” as per Drugs & Cosmetics Act, 1940 for the testing of Copper T and Tubal Rings ( Intrauterine Contraceptive Devices.)
Analysis of Import drugs & Cosmetics samples entering through the port offices.
Analysis of Registration samples for approval of site registration as per GMP.
Analysis of New Drugs to get license for manufactring the same.
Analysis of Drugs & Pharmaceutical formulations received as Survey Samples from Central Drugs Standard Control Organization and its Zonal Offices.
Analysis of Drugs & Pharmaceuticals formulations received as national Survey samples from CDSCO or other offices under Ministry of Health & Family Welfare
Imparting Training to Drugs Analysts deputed by the Government laboratories form time to time.
To undertake anlytical research on standaridization and methodology of Drugs.
To act as Sub-Office/Lab of IPC, in developing standards both of Monographs and Reference Standards development process of Indian Pharmacopoeia.
Information Under the Right to Information Act 2005
Central Public Information Officer (CPIO)
Ms. Sayali U.Warde,
Sr. Scientific Officer-II & CPIO
Central Drugs Testing Laboratory,
CDSCO, Zonal FDA Bhawan
GMSD Compound, Bellasis Road,
Mumbai Central Mumbai 400008
Ms. Manasi M. Patel,
Sr. Scientific Officer-I
Central Drugs Testing Laboratory,
CDSCO, Zonal FDA Bhawan
GMSD Compound Bellasis Road
Mumbai Central Mumbai-400 008
Central Drugs Testing Laboratory Mumbai Profile
Central Drugs Testing Laboratory Mumbai Annual Report 2015-2016
Central Drugs Testing Laboratory (CDTL) Chennai , Tamil Nadu
Central Drug Testing Laboratory is one of the Seven National Laboratories in India engaged in the research and analysis of Drug and Cosmetics as per Drug and Cosmetics Act, 1940.
The Director of the CDTL Chennai is, Dr. N. Murugesan, Director , Central Drug Testing Laboratory, Govt. of India, 37, Naval Hospital Road, Periamet, Campus G.M.S.D., Chennai – 600 003. Phone : 044-25610402/ 25610205, Gram : DRUGSLAB, Fax : 044 -25610906 E-mail : firstname.lastname@example.org
Central Drugs Testing Laboratory (CDTL) Hyderabad, AP
Central Drug Testing Laboratory is one of the Newly established Laboratories in the state of Andhra Pradesh, India engaged in testing , research and analysis of Drug and Cosmetics as per Drug and Cosmetics Act, 1940.
The Director (incharge)/ Nodal Officer of the CDTL Hyderabad is, Dr. N. Murugesan, Central Drug Testing Laboratory, CDSCO, Zonal office Hyderabad , CDSCO BHAVAN, Beside T.B. & Demonstration Centre, S.R. Nagar, Hyderabad - 500038, A.P . Phone : 040-23811327/, Fax : 040- 23811328, E-mail : email@example.com
Regional Drugs Testing Laboratory (RDTL) Guwahati
The Regional Drugs Testing Laboratory Guwahati is the one of the five National Laboratory of the Govt of India for quality control of Drugs and Cosmetic and is established under the Indian Drugs & Cosmetics Act 1940 functioning under administrative control of the Drugs Controller General of India and sub ordinate office under Directorate General of Health Services, Ministry of Health & Family Welfare. The laboratory was set up in the year 2002 for entire North Eastern State including Sikkim and is housed in its own building at Guwahati.
1. Statutory Function:
a. Analytical quality control of drugs and cosmetic manufactured within the country on behalf of the Central and State Drugs Controller Administration.
b. To assists the Central Drugs Standard Control Organization in the testing of Drugs and cosmetic.
The laboratory is headed by
Dr. Parthajyoti Gogoi, Director-in-Charge Regional Drugs Testing Laboratory, Directorate General of Health Services, Guwahati-781 037 (Assam)
Phones -Off- 0361-2338555/2330555(Fax) ,Resi-0361-2337272/2330899
e-mail : firstname.lastname@example.org , mailto: %email@example.com , firstname.lastname@example.org
Regional Drugs Testing Laboratory (RDTL) Chandigarh
The Regional Drugs Testing Laboratory, Chandigarh is the one of the six National Laboratories of the Govt of India functioning under the administrative control of the Drug Controller General (India), Central Drugs Standard Control Organisation, Directorate General of Health Services, Ministry of Health & Family Welfare. The Laboratory has been established for quality control of Drugs and Cosmetic under the Indian Drugs & Cosmetics Act 1940. This laboratory is engaged in the analysis of bulk drugs & formulations referred by the Deputy Drugs Controller (India), Assistant Drugs Controller (India) and Drugs Inspectors from CDSCO North Zone, Ghaziabad, CDSCO Sub-Zone Chandigarh and CDSCO Sub-Zone Jammu. The Regional Drugs Testing Laboratory, Chandigarh has become operational since November, 2007. Presently the laboratory is testing the legal (Form-18) and survey samples at an average of 150 per month. The laboratory is in the process of up-gradation in infrastructure and manpower in order to increase the testing capacity
Regional Drugs Testing Laboratory, Sector 39-C, Chandigarh 160036, Director : Dr. R.A Singh, Phone : 0172 - 2688239; Fax 0172-2636316, e- mail :email@example.com
Central Drug Laboratory, CRI Kasauli
Central drug laboratory at CRI Kasauli is a Central laboratory engaged in the testing of vaccines. It is a notified laboratory under the Drugs and cosmetics Act, 1940 to function as Central drugs laboratory for testing of the following drugs or classes of drugs;
ii) Solution of serum proteins intended for injection
vii) Sterilized surgical ligature and sterilized surgical suture
viii) Bacteriophages, including Oral Polio vaccine.
The Director of the Central Research Institute is an ex-officio member of DTAB.
The Director of CRI kasauli is Dr. K.R.Mani, Phone: 01792-272060, 272059, 272114; Fax: 01792 -272049
Indian Pharmacopoeial Commission (IPC)
Indian Pharmacopoeial Commission is an Autonomous Institution under the Ministry of Health & Family Welfare, Govt. of India dedicated for setting of standards for drugs, pharmaceuticals and healthcare devices/ technologies etc besides providing Reference Substances and Training. Its functions are :
a) To develop comprehensive monographs for drugs to be included in the Indian Pharmacopoeia, including active pharmaceutical ingredients, excipients and dosage forms as well as medical devices, and to keep them updated by revision on a regular basis.
b) To accord priority to monographs of drugs included in the national Essential Drugs List and their dosage forms.
c) To prepare monographs for products that have normally been in the market for not less than 2 years except for certain special categories of new drugs like antiretrovirals, antituberculosis and anticancer drugs and their formulations introduced more recently, which may be accorded priority attention
d) To give special attention to the methods of manufacture used by the indigenous industry in selecting the pharmacopoeial tests for monitoring the toxic impurities of the concerned drug.
e) To take note of the different levels of sophistication in analytical testing/instrumentation available while framing the monographs.
f) To accelerate the process of preparation, certification and distribution of IP Reference Substances, including the related substances, impurities and degradation products required.
g) To collaborate with pharmacopoeias like the Ph Eur, BP, USP, JP and International Pharmacopoeia with a view to harmonizing with global standards.
h) To organize educational programs and research activities for spreading and establishing awareness on the need and scope of quality standards for drugs and related articles/ materials.
The Indian Pharmacopoeia Commission has been registered as a Society under the provisions of the Societies Registration Act, 1860(Act No. 21 of 1860) for the registration of Literary, Scientific and Charitable Societies, on 09 December 2004.
The Director of Indian Pharmacopoeial Commission is Dr. G.N. Singh, Raj Nagar, Sector -23, Ghaziabad 201002 (U.P) Phone: 95120- 2783401(D) 2783337; Fax: 091 -24783311, E-mail : firstname.lastname@example.org